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Introduction: Gentamicin is a commonly used antibiotic against infectious Gram negative bacteria. However, 
the clinical use of gentamicin over prolonged periods is limited because of dose- and time-dependent 
nephrotoxicity. Primarily, lysosomal phospholipidosis, generation of intracellular reactive oxygen species and 
heightened inflammation have been implicated. Hydrogen sulphide (H2S) is a small gaseous, endogenously 
produced signal transduction molecule with antioxidant, anti-inflammatory, antiapoptotic and cytoprotective 
properties. In kidneys for example, the production of endogenous H2S by cystathionine-γ-lyase was found to limit 
oxidative stress, renal ischemic-reperfusion injury and dysfunction. We hypothesized that H2S ameliorates 
gentamicin-induced toxicity, preventing nephron necrosis and renal dysfunction. 
Methods: Adult female Sprague-Dawley rats were divided into six groups (n = 4–8 animals) and then treated for 10 
days with; physiological saline only, sodium hydrosulphide (NaHS; an exogenous H2S-donor, 50 µmoles/Kg/day, 
i.p) only, DL-propargyl glycine (PAG; an irreversible inhibitor of cystathionine-γ-lyase, 25 mg/Kg/day, i.p) only, 
gentamicin (100 mg/Kg/day, i.p) only, a combination of getamicin and NaHS, or gentamicin and PAG respectively. 
Blood samples and kidneys were collected for biochemical, histological and morphometric analysis. 
Results & Discussion: Nephrotoxic effects of gentamicin were not altered by administering NaHS but PAG 
significantly attenuated the toxic effects of gentamicin thus improving renal function (* P < 0.001 compared to 
saline controls and # P < 0.001 compared to gentamicin only).   
          
 
                             
Gentamicin-induced histopathological changes including tubular necrosis, oedema and infiltration of the interstitium 
by inflammatory cells were attenuated by co-administering gentamicin with PAG. These data show that inhibition of 
the endogenous biosynthesis of H2S reduces gentamicin-induced renal damage. This effect might be related, at least 
in part, to the reduced inflammatory responses observed in animals treated with both gentamicin and PAG. 
Endogenous H2S and enzyme systems involved in its biosynthesis may offer a viable therapeutic target in alleviating 
the nephrotoxic effects of gentamicin.   
 
 
 
 
 
 
